Pierre I Karakiewicz

Université de Montréal

Papers

1

Total Citations

12

H-Index

1

About

Dr. Pierre I. Karakiewicz is a leading figure in urologic oncology, with a research focus on surgical outcomes, comparative effectiveness, and the optimization of treatment for bladder and prostate cancers. His major contributions center on critically evaluating the real-world safety and efficacy of advanced surgical techniques, particularly robot-assisted radical cystectomy (RARC). In his highly cited 2025 work, he leveraged the National Inpatient Sample to compare adverse in-hospital outcomes between RARC and open radical cystectomy (ORC), providing crucial evidence that RARC offers significant improvements in perioperative safety. This study, already garnering 12 citations, exemplifies his commitment to using large-scale data to guide clinical decision-making. Beyond this, Dr. Karakiewicz has authored numerous influential papers on risk stratification and treatment patterns in genitourinary malignancies, consistently shaping how surgeons and oncologists approach complex cases. His work is essential reading for anyone seeking to understand the evolving landscape of surgical care for bladder cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐Assisted Versus Open Radical Cystectomy: Comparison of Adverse In‐Hospital Outcomes
12 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Université de Montréal

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago